Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick L Green

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Journal of Virology|January 9, 2024
An HTLV-1 envelope mRNA vaccine is immunogenic and protective in New Zealand rabbitsJoshua J Tu, Emily King, Victoria Maksimova, et al.
Plos Pathogens|February 25, 2011
HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivoYorifumi Satou, Jun-Ichirou Yasunaga, Tiejun Zhao, et al.
Journal of Bone Oncology|December 25, 2019
Mouse model recapitulates the phenotypic heterogeneity of human adult T-cell leukemia/lymphoma in boneNicole A Kohart, Said M Elshafae, Wachirapan Supsahvad, et al.
Blood Advances|January 14, 2022
Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphomaAnusara Daenthanasanmak, Richard N Bamford, Makoto Yoshioka, et al.
Blood|September 23, 2006
Human T-cell leukemia virus type-1 Tax oncoprotein regulates G-protein signalingJean-Claude Twizere, Jean-Yves Springael, Mathieu Boxus, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2013
BET proteins promote efficient murine leukemia virus integration at transcription start sitesAmit Sharma, Ross C Larue, Matthew R Plumb, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 19, 2024
Vulnerability to APOBEC3G linked to the pathogenicity of deltaretrovirusesTakafumi Shichijo, Jun-Ichirou Yasunaga, Kei Sato, et al.
Annual Review of Genetics|August 31, 2017
Human Genetic Determinants of Viral DiseasesAdam D Kenney, James A Dowdle, Leonia Bozzacco, et al.
Oncotarget|October 21, 2017
HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic miceAlison K Esser, Daniel A Rauch, Jingyu Xiang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 2017
PRMT5-Selective Inhibitors Suppress Inflammatory T Cell Responses and Experimental Autoimmune EncephalomyelitisLindsay M Webb, Stephanie A Amici, Kyle A Jablonski, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Journal of Virology|January 9, 2024
An HTLV-1 envelope mRNA vaccine is immunogenic and protective in New Zealand rabbitsJoshua J Tu, Emily King, Victoria Maksimova, et al.
Plos Pathogens|February 25, 2011
HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivoYorifumi Satou, Jun-Ichirou Yasunaga, Tiejun Zhao, et al.
Journal of Bone Oncology|December 25, 2019
Mouse model recapitulates the phenotypic heterogeneity of human adult T-cell leukemia/lymphoma in boneNicole A Kohart, Said M Elshafae, Wachirapan Supsahvad, et al.
Blood Advances|January 14, 2022
Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphomaAnusara Daenthanasanmak, Richard N Bamford, Makoto Yoshioka, et al.
Blood|September 23, 2006
Human T-cell leukemia virus type-1 Tax oncoprotein regulates G-protein signalingJean-Claude Twizere, Jean-Yves Springael, Mathieu Boxus, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2013
BET proteins promote efficient murine leukemia virus integration at transcription start sitesAmit Sharma, Ross C Larue, Matthew R Plumb, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 19, 2024
Vulnerability to APOBEC3G linked to the pathogenicity of deltaretrovirusesTakafumi Shichijo, Jun-Ichirou Yasunaga, Kei Sato, et al.
Annual Review of Genetics|August 31, 2017
Human Genetic Determinants of Viral DiseasesAdam D Kenney, James A Dowdle, Leonia Bozzacco, et al.
Oncotarget|October 21, 2017
HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic miceAlison K Esser, Daniel A Rauch, Jingyu Xiang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 2017
PRMT5-Selective Inhibitors Suppress Inflammatory T Cell Responses and Experimental Autoimmune EncephalomyelitisLindsay M Webb, Stephanie A Amici, Kyle A Jablonski, et al.
Pageof 8